Researchers ID Molecular Subtypes of Gastric Cancer Predictive of Survival and Drug Response

In a step toward personalizing treatments for gastric cancer, a recently published study showed that molecularly defined disease subtypes respond differently to therapies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.